Literature DB >> 20819984

Impaired intellect and memory: a missing link between genetic risk and schizophrenia?

Timothea Toulopoulou1, Terry E Goldberg, Irene Rebollo Mesa, Marco Picchioni, Fruhling Rijsdijk, Daniel Stahl, Stacey S Cherny, Pak Sham, Stephen V Faraone, Ming Tsuang, Daniel R Weinberger, Larry J Seidman, Robin M Murray.   

Abstract

CONTENT: The DSM-IV concept of schizophrenia offers diagnostic reliability but etiologic and pathologic heterogeneity, which probably contributes to the inconsistencies in genetic studies. One solution is to identify intermediate phenotypes, "narrower" constructs of liability, that hypothetically share genetic risk with the disorder. Although a variety of candidate intermediate phenotypes have emerged, few have explicitly quantified the extent of their genetic overlap with schizophrenia.
OBJECTIVE: To quantify the net-shared genetic effects between schizophrenia and specific cognitive candidate intermediate phenotypes.
DESIGN: Twin and family design.
SETTING: Adult psychiatric research centers in the United States and the United Kingdom. PARTICIPANTS: A total of 2056 participants: 657 patients with schizophrenia, 674 first-degree relatives (including co-twins), and 725 controls. MAIN OUTCOME MEASURES: (1) Latent factors capturing the common variance between cognitive tasks, (2) separation of the latent factors into their genetic and environmental components, and (3) estimation of the net-shared genetic variance between the latent cognitive factors or intelligence and schizophrenia.
RESULTS: Genetic factors contributed substantially to the total variance in cognition (immediate recall latent factor: 0.66; 95% confidence interval [CI], 0.62 to 0.85; delayed recall latent factor: 0.48; 0.42 to 0.55; and intelligence: 0.66; 0.62 to 0.71). The latent common factors for modality-specific immediate and delayed recall and intelligence showed similar levels of phenotypic covariance with schizophrenia (immediate recall: -0.35; delayed recall: -0.37; and intelligence: -0.38), with 72%, 86%, and 89%, respectively, due to shared genetic effects with schizophrenia. Environmental effects accounted for little phenotypic correlation between cognition and schizophrenia.
CONCLUSIONS: Using the largest international familial schizophrenia cohort to date, we showed that a substantial portion of the phenotypic correlation between schizophrenia and cognition is caused by shared genetic effects. However, because the phenotypic and genetic correlations are far from unity, the genetics of schizophrenia are clearly not merely the genetics of cognition.

Entities:  

Mesh:

Year:  2010        PMID: 20819984     DOI: 10.1001/archgenpsychiatry.2010.99

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  49 in total

1.  Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation.

Authors:  Alysa E Doyle; Pieter J Vuijk; Nathan D Doty; Lauren M McGrath; Brian L Willoughby; Ellen H O'Donnell; H Kent Wilson; Mary K Colvin; Deanna C Toner; Kelsey E Hudson; Jessica E Blais; Hillary L Ditmars; Stephen V Faraone; Larry J Seidman; Ellen B Braaten
Journal:  J Int Neuropsychol Soc       Date:  2017-08-04       Impact factor: 2.892

2.  Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.

Authors:  David T Liebers; Mehdi Pirooznia; Fayaz Seiffudin; Katherine L Musliner; Peter P Zandi; Fernando S Goes
Journal:  Schizophr Bull       Date:  2016-02-12       Impact factor: 9.306

Review 3.  The genetics of cognitive impairment in schizophrenia: a phenomic perspective.

Authors:  Robert M Bilder; Andrew Howe; Nic Novak; Fred W Sabb; D Stott Parker
Journal:  Trends Cogn Sci       Date:  2011-08-02       Impact factor: 20.229

4.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 5.  Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis.

Authors:  Gabriëlla A M Blokland; Raquelle I Mesholam-Gately; Timothea Toulopoulou; Elisabetta C Del Re; Max Lam; Lynn E DeLisi; Gary Donohoe; James T R Walters; Larry J Seidman; Tracey L Petryshen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

6.  IQ, the Urban Environment, and Their Impact on Future Schizophrenia Risk in Men.

Authors:  Timothea Toulopoulou; Marco Picchioni; Preben Bo Mortensen; Liselotte Petersen
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

7.  Altered cerebral response during cognitive control: a potential indicator of genetic liability for schizophrenia.

Authors:  Fabio Sambataro; Venkata S Mattay; Kristina Thurin; Martin Safrin; Roberta Rasetti; Giuseppe Blasi; Joseph H Callicott; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

8.  Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort.

Authors:  T Toulopoulou; N van Haren; X Zhang; P C Sham; S S Cherny; D D Campbell; M Picchioni; R Murray; D I Boomsma; H E Hulshoff Pol; H H Pol; R Brouwer; H Schnack; L Fañanás; H Sauer; I Nenadic; M Weisbrod; T D Cannon; R S Kahn
Journal:  Mol Psychiatry       Date:  2014-12-02       Impact factor: 15.992

Review 9.  Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.

Authors:  Jessica Agnew-Blais; Larry J Seidman
Journal:  Cogn Neuropsychiatry       Date:  2012-09-21       Impact factor: 1.871

10.  Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.

Authors:  Francesco Papaleo; Feng Yang; Clare Paterson; Sara Palumbo; Gregory V Carr; Yanhong Wang; Kirsten Floyd; Wenwei Huang; Craig J Thomas; Jingshan Chen; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.